Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Bonner

Showing results (21-30 of 184) with videos related to

Pageof 19
Sort By:
Current Environmental Health Reports|February 15, 2018
The Toxicology of Engineered Nanomaterials in AsthmaMark D Ihrie, James C Bonner
Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology|October 7, 2017
Mechanisms of carbon nanotube-induced pulmonary fibrosis: a physicochemical characteristic perspectiveKatherine S Duke, James C Bonner
Comparative Biochemistry and Physiology. C, Comparative Pharmacology and Toxicology|January 1, 1987
Comparative acute toxicity of DDT metabolites among American and European species of planariansJ C Bonner, M R Wells
FEMS Microbiology Immunology|December 1, 1991
Cytofluorometric analysis of anti-lymphocyte antibodies in AIDSB C Bonner, T A Poulton
Current Molecular Medicine|August 12, 2006
EGF and PDGF receptor tyrosine kinases as therapeutic targets for chronic lung diseasesJennifer L Ingram, James C Bonner
American Journal of Respiratory Cell and Molecular Biology|April 27, 2000
Mechanism of extracellular signal-regulated kinase (ERK)-1 and ERK-2 activation by vanadium pentoxide in rat pulmonary myofibroblastsY Z Wang, J C Bonner
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1989
Role of the brain t-butylbicyclophosphorothionate receptor in vertebrate resistance to endrin, 1,1,1-trichloro-2,2-bis(p-chlorophenyl)ethane and cypermethrinJ C Bonner, J D Yarbrough
International Journal of Molecular Sciences|October 7, 2020
Susceptibility Factors in Chronic Lung Inflammatory Responses to Engineered NanomaterialsDorothy J You, James C Bonner
Chest|March 1, 1991
Asbestos-induced alveolar injury. Evidence for macrophage-derived PDGF as a mediator of the fibrogenic responseJ C Bonner, A R Brody
Diabetes & Metabolism|July 19, 2018
SGLT2 inhibition and glucagon secretion in humansC Saponaro, F Pattou, C Bonner
Pageof 19

Showing results (21-30 of 184) with videos related to

Sort By:
Pageof 19
Current Environmental Health Reports|February 15, 2018
The Toxicology of Engineered Nanomaterials in AsthmaMark D Ihrie, James C Bonner
Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology|October 7, 2017
Mechanisms of carbon nanotube-induced pulmonary fibrosis: a physicochemical characteristic perspectiveKatherine S Duke, James C Bonner
Comparative Biochemistry and Physiology. C, Comparative Pharmacology and Toxicology|January 1, 1987
Comparative acute toxicity of DDT metabolites among American and European species of planariansJ C Bonner, M R Wells
FEMS Microbiology Immunology|December 1, 1991
Cytofluorometric analysis of anti-lymphocyte antibodies in AIDSB C Bonner, T A Poulton
Current Molecular Medicine|August 12, 2006
EGF and PDGF receptor tyrosine kinases as therapeutic targets for chronic lung diseasesJennifer L Ingram, James C Bonner
American Journal of Respiratory Cell and Molecular Biology|April 27, 2000
Mechanism of extracellular signal-regulated kinase (ERK)-1 and ERK-2 activation by vanadium pentoxide in rat pulmonary myofibroblastsY Z Wang, J C Bonner
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1989
Role of the brain t-butylbicyclophosphorothionate receptor in vertebrate resistance to endrin, 1,1,1-trichloro-2,2-bis(p-chlorophenyl)ethane and cypermethrinJ C Bonner, J D Yarbrough
International Journal of Molecular Sciences|October 7, 2020
Susceptibility Factors in Chronic Lung Inflammatory Responses to Engineered NanomaterialsDorothy J You, James C Bonner
Chest|March 1, 1991
Asbestos-induced alveolar injury. Evidence for macrophage-derived PDGF as a mediator of the fibrogenic responseJ C Bonner, A R Brody
Diabetes & Metabolism|July 19, 2018
SGLT2 inhibition and glucagon secretion in humansC Saponaro, F Pattou, C Bonner
Pageof 19